The role of angiotensinogen, angiotensin II receptor type I and type II receptor polymorphisms (AGTR2 rs11091046, AGT rs699, AGTR1 rs5186, and AGT rs4762) in multiple myeloma

The role of angiotensinogen, angiotensin II receptor type I and type II receptor polymorphisms (AGTR2 rs11091046, AGT rs699, AGTR1 rs5186, and AGT rs4762) in multiple myeloma

Abstract Objective This study aimed to elucidate the impact of angiotensinogen (AGT), and angiotensin II receptor type I and type II (AGTR1/2) polymorphisms (AGTR2 rs11091046, AGT rs699, AGTR1 rs5186, and AGT rs4762) on multiple myeloma (MM) susceptibility, treatment response, and survival outcomes....

Full description

Saved in:
Bibliographic Details
Main Authors: Istemi Serin, Yasemin Oyaci, Sacide Pehlivan, Elif Ertas, Fatma Ceren Tuncel, Mustafa Pehlivan
Format: Article
Language:English
Published: Springer 2025-08-01
Series:Discover Oncology
Subjects:
Multiple myeloma
Angiotensinogen
Polymorphisms
Response
Survival
Online Access:https://doi.org/10.1007/s12672-025-03443-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-03443-w

Similar Items